Journal
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Volume 18, Issue 10, Pages 973-976Publisher
WILEY
DOI: 10.1002/pds.1802
Keywords
diabetes; medical therapy; prescribing patterns
Funding
- Canadian Institutes of Health Research (CIHR) [MOP-81284]
- Canadian Foundation for Innovation (CFI)
- les Fonds de la Recherche en Sante du Quebec
- Faculty of Medicine of McGill University
- Research Institute of the McGill University Health Centre
- Department of Medicine of the McGill University Health Centre
Ask authors/readers for more resources
Purpose Over the last decade, guidelines for the treatment of type 2 diabetes have increasingly favored tighter glycemic control, necessitating the use of more aggressive pharmacological therapy. The objective of this study was to describe trends in the prescription of antidiabetic medications among patients with type 2 diabetes in the United Kingdom (UK). Methods Using the General Practice Research Database, we constructed a cohort of patients with type 2 diabetes. Diabetes was defined as the presence of a diagnosis of diabetes, HbA1c >= 7%, or >= 2 prescriptions for anti-diabetic medications. Analyses were conducted for the full cohort as well as a sub-cohort with incident diabetes. Results Our full cohort involved 67 981 patients and a total of 320 089 patient-years, and our sub-cohort involved 30 234 patients with incident diabetes and 111 890 patient-years. From 2000 to 2006, there was a substantial increase in the prescription rate of anti-diabetic medications. Overall, there were 9.6 prescriptions/patient-year in 2000, and this had increased to 14.8 prescriptions/patient-year in 2006. The greatest relative increase occurred in the prescription of thiazolidinediones. The greatest absolute increase occurred in the prescription of metformin, which surpassed sulfonylureas as the most commonly prescribed anti-diabetic medication among patients with type 2 diabetes in 2002. Among those with incident diabetes, overall prescription rates were 4.6 prescriptions/patient-year in 2000 and 13.6 prescriptions/patient-year in 2006. Conclusions There was a substantial increase between 2000 and 2006 in the UK in the prescription of anti-diabetic medications. This increasingly aggressive pharmacological management is consistent with recent practice guidelines. Copyright (C) 2009 John Wiley & Sons, Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available